Global Genome Editing Market By Technique (CRISPR, TALENs, Zinc Finger Nucleases, Others), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others), By Delivery Method (Ex-vivo, In-vivo), By End User (Pharmaceutical & Biotechnology Companies, Clinical Research Organization, Research Institutes), By Region, Competition Forecast & Opportunities, 2019-2029

Global genome editing market is

Genome editing is a way of making specific changes to the DNA of a cell or organism. It could be used to edit the genome of any organism. It uses a type of enzyme called an ‘engineered nuclease’ which cuts the genome in a specific place. After cutting the DNA in a specific place, the cell naturally repairs itself. It finds application in large number of areas, such as mutation, therapeutics, and agriculture biotechnology.

The global genome editing market is segmented based on

Based on end-user, the global genome editing market is segmented into pharmaceutical & biotechnology companies, clinical research organization and research institutes. Pharmaceutical & biotechnology companies contribute to the largest share of revenue generation for global genome editing market. Growing establishment of biotech and pharma companies in emerging economies and growing usage of gene editing technique in research activities undertaken by them to manufacture and develop drugs for rare diseases are the enablers for the growth of the market.

The major players operating in the global genome editing market are Thermo Fisher Scientific Inc., Homology Medicines, Inc., CRISPR Therapeutics AG, Pfizer Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Cellectis SA, Sangamo Therapeutics Inc., Origene Technologies Inc., Merck & Co Inc., New England Biolabs Inc., Lonza Group AG, Danaher Corporation (Integrated DNA Technologies Inc.), PerkinElmer Inc. (Horizon Discovery Group Plc), Genscript Corp., Oxford Genetics Ltd., Bayer AG, Arcturus Therapeutics Inc, Inscripta Inc., Beam therapeutics Inc. and others. Growing number of research and development is going to drive the genome editing market in the coming years.

Years considered for this report

Historical Years2019-2022

Base Year2023

Estimated Year2024

Forecast Period2025– 2029

Objective of the Study

• To analyze the historical growth in the market size of global genome editing market from 2019 to 2022.
• To estimate and forecast the market size of global genome editing market from 2023 to 2029 and growth rate until 2029.
• To classify and forecast global genome editing market based on technique, application, delivery method, end user, company and region.
• To identify drivers and challenges for global genome editing market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global genome editing market.
• To conduct pricing analysis for global genome editing market.
• To identify and analyze the profile of leading players operating in global genome editing market.

Click here to download the sample

Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of companies across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the companies which could not be identified due to the limitations of secondary research. Market insights research analyzed the presence of all major players across the globe.

Market insights research calculated the market size of

Key Target Audience

• Genome editing companies
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to genome editing

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.